BullishWhales · Analysts · Analyst Profile
Analyst rating accuracy & track record
Brian Cheng does not yet have enough resolved 12-month calls to carry a published score. Check back as their ratings mature.
Ratings & price targets
| Stock | Rating | Price target | Rated | 12-mo vs sector | PT hit |
|---|---|---|---|---|---|
 CGONCG Oncology, Inc. Common stock | Buy | $41.00 | May 2025 | +133.6% | Hit |
 AAPGAscentage Pharma Group International | Buy | — | Mar 2025 | +5.5% | — |
 EDITEditas Medicine Inc | Sell | — | Dec 2024 | −52.5% | — |
 ZYMEZymeworks Inc. Common Stock | Buy | $18.00 | Dec 2024 | +80.7% | Hit |
 XNCRXencor Inc | Buy | $28.00 | Nov 2024 | −40.2% | Miss |
| XNCRXencor Inc | Buy | $27.00 | Jul 2024 | −45.9% | Hit |
 KYTXKyverna Therapeutics, Inc. Common Stock | Buy | $33.00 | Jul 2024 | −42.3% | Miss |
 IMNMImmunome Inc | Buy | $24.00 | Apr 2024 | −41.7% | Miss |
 PGENPrecigen Inc | Sell | — | Mar 2024 | −26.1% | — |
| KYTXKyverna Therapeutics, Inc. Common Stock | Buy | $39.00 | Mar 2024 | −94.4% | Miss |
 BCABBioatla Inc | Buy | $14.00 | Sep 2023 | −24.1% | Miss |
| BCABBioatla Inc | Buy | $17.00 | Aug 2023 | −57.3% | Miss |
| BCABBioatla Inc | Buy | $19.00 | Apr 2023 | +12.4% | Miss |
Go to
Browse the full analyst leaderboardHow analyst accuracy is scored
Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.